Orthobiologics Market Size up to 2030 - Quantitative Research by QYResearch Medical

The global orthobiologics market size was USD 5.58 Billion in 2020 and is expected to register a CAGR of 5.1% during the forecast period.

Steady revenue growth of orthobiologics market can be attributed to growing use of viscosupplementation products in the healthcare sector for various surgical procedures. Rising number of orthopedic procedures due to growing geriatric population and obese people, and increasing awareness about advanced technological procedures are driving market revenue growth. 

People deal with body pains in certain moments of their lives. These body pains, tragically, are not just about joints and bones. Human body has a large system of muscles, tendons, and cartilage that suffers from strain every day. Aged people suffer from gradual physical deterioration, which is the major cause for most pains. Orthobiologics have advanced to the extent that it can substantially influence modern orthopedical and surgical procedures.

Inquiry before Buying@ https://qyresearchmedical.com/submit-inquiry/118242

Orthobiologics are also called regenerative cell treatments. There are various types of orthobiologics present in the market depending on distinct functional mechanism. An autologous is obtained from patient’s body which under optimal conditions are separated to form progenitor cells. Orthobiologics is used in various applications for treatment of disorders such as fracture recovery, spinal fusion, and others. These are available for ankle, hip, knee, spine wrists and other parts of the body. Orthobiologics primarily helps in quicker recuperating of wounds.

Products that are associated with Orthobiologics contain growth factors or discharge development components that assist in tissue recuperating, improve pain symptoms, and further helps to restore proper functioning of body parts. A better understanding and knowledge of roles played by different growth factors in healing of tendons, ligament repair, regeneration of cartilage, and bone formation has encouraged research in numerous ongoing musculoskeletal disorders.

Market Dynamics:
Driver: Rising demand for the Viscosupplementation Products is the key revenue growth driving factors

Orthobiologics market is expected to register a robust revenue growth rate during the forecast period. Viscosupplements are injections containing hyaluronic acid, which are directly inserted into the joints. Viscosupplements are broadly utilized in the treatment of knee osteoarthritis, which is one of the serious issues among geriatric population. Better product costs, new market players, modern marketing endorsement are factors driving demand for viscosupplementation products. Favorable reimbursement policies, increasing healthcare expenditure, and high demand for viscosupplementation products are expected to drive the orthobiologics market revenue growth. 

Restraint: High cost of Orthobiologics Products and Procedures are key growth restraining factors

Challenges in advancements and clinical trials of the orthobiologics, and high costs of product and procedure, complicated amalgamation processes, stringent rules and regulations for product production, and high manufacturing cost are factors that can hamper market revenue growth. Additionally, complications after surgery could lower adoption rate of orthobiologics products, which can hamper market growth to some extent.

Related Reports:

Product Type Outlook:

Based on product type, the global orthobiologics market has been segmented into viscosupplementation products, demineralized bone matrices, synthetic orthobiologics, bone morphogenic protein, allografts, and plasma-rich protein. Viscosupplementation products segment has accounted for the largest market share in 2020. Viscosupplementation is a methodology dependent on the substitution of synovial fluid or exudates with elastoviscous hyaluronan arrangement. Viscosupplementation might be a helpful alternative for people with osteoarthritis of knees. The essential objectives of treatment are to get relief from pain and reestablish proper functioning. Viscosupplementation products are gel like substances, hyaluronates, that imitate properties of natural fluid present in the joints. Synthetic orthobiologics segment is expected register a significantly high revenue CAGR over the forecast period.

End Use Outlook:

Based on end use, the global orthobiologics market has been segmented into hospitals, orthopedic clinics, research & academic institutes, dental clinics and facilities, and ambulatory care centers. Hospital segment accounted for the largest revenue share in 2020 because of increasing number of cosmetic and spinal surgeries performed in the hospitals as compared to other healthcare facilities, and rising number of multi-specialty hospitals and modern orthopedic treatment procedures. Orthopedic clinics segment is expected register a significantly high revenue CAGR over the forecast period.

Application Outlook:

Based on application, the global orthobiologics market has been segmented into osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injury, fracture recovery and reconstructive surgery, and maxillofacial and dental applications. Osteoarthritis and degenerative arthritis segment accounted for largest revenue share in 2020, due to Growing geriatric population, and rising prevalence of age-related bone disorders. Osteoarthritis is a type of disorder which occurs when protective cartilages that supports the closures of bones wears out after some time. Osteoarthritis can harm any joint, but it normally affects the knee, hip, spinal joints.

Spinal fusion is a type of surgery which emphasizes on reconnecting vertebra. The fusion of vertebra holds them which is a reason for back pain. Spinal fusion helps to reduce back pain because after surgery there are very less chances of overstretching of nerves, muscles, and ligaments. Increasing number of injuries in sports and road accidents lead to spinal fusion and soft-tissue injuries which further drives the orthobiologics market.

Regional Outlook:

Orthobiologics market in North America accounted for the largest revenue share in 2020, due to key drivers, such as increase in the number of overweight people which increases cases of orthopedic surgeries, advanced surgical procedures, increased fund allocation, and rising awareness among people. Sophisticated technologies and well-developed healthcare infrastructure are also responsible for regional growth. 

Orthobiologics market revenue in Asia Pacific is expected to witness the fastest CAGR over the forecast period, due to the presence of large number of market players and government initiatives for advanced treatments. The APAC region has a large number of patients with disorders and injuries and high demand of reconstructive surgeries, which in turn contribute to the market growth. 

Competitive Landscape: 

Competitive landscape of the global Orthobiologics market is moderately fragmented with a number of key players operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand their respective product portfolio and gain a robust footing in the global market. Major players in the market include Arthrex, Bioventus, DePuy Synthes (Subsidiary of Johnson & Johnson), Globus Medical Inc., Orthofix, RTI Surgical, Sanofi-Genzyme, SeaSpine Holdings, Smith & Nephew, Stryker Corporation, Zimmer Biomet.

Some key developments in the market:

  • In 2021, Orthofix Medical Inc., a global medical device company that focuses on providing reconstructive and regenerative orthopedic & spine solutions to physicians, has announced the U.S. and European full market Launch FITBONE intramedullary lengthening and deformity correction of the femur and tibia bones.
  • In March 2019, Bioventus launched OSTEOAMP SELECT fibers an allograft for spine, foot, and ankle, orthopedic and trauma patients, giving surgeons more options for bone healing and remodeling while delivering positive patients outcomes.

Segments Covered in the Report:

This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the sub-segments from 2018 to 2030. For this study, Reports and Data has segmented the global orthobiologics market based on product type, end use, application, and region:

Inquiry before Buying@ https://qyresearchmedical.com/submit-inquiry/118242

Orthobiologics Market Report Scope

Segments covered By Product Type Outlook, End Use, Application Outlook, Regional Outlook

By Product Type Outlook            

  • Viscosupplementation Products
  • Demineralized Bone Materials
  • Synthetic Orthobiologics
  • Bone Morphogenic
  • Allografts
  • Plasma-Rich Protein
  • Bone Marrow Aspirate Concentrate

By End Use        

  • Hospitals
  • Orthopedic Clinics
  • Research & Academic Institutes
  • Dental Clinic and Facilities
  • Ambulatory Care Centers

By Application Outlook

  • Osteoarthritis and Degenerative Arthritis
  • Spinal Fusion
  • Soft-Tissue Injuries
  • Fracture Recover and Reconstructive Surgery
  • Maxillofacial and Dental Applications

Regional scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118242/1500

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:

URL - http://www.qyresearchmedical.com/





Back to news